phloretin has been researched along with Osteoporosis, Postmenopausal in 1 studies
Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phloretin was effective in preventing estrogen deficiency-induced osteoclastogenic resorption." | 1.40 | Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice. ( Gong, JH; Kang, MK; Kang, YH; Kim, JL; Kim, YH; Lee, EJ, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, EJ | 1 |
| Kim, JL | 1 |
| Kim, YH | 1 |
| Kang, MK | 1 |
| Gong, JH | 1 |
| Kang, YH | 1 |
1 other study available for phloretin and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice.
Topics: Animals; Apoptosis; Bone Resorption; Cell Differentiation; Cell Line, Tumor; Disease Models, Animal; | 2014 |